Abstract:Objective To investigate the correlation of plasma matrix metaUoproteinase-3 （MMP-3） levels and MMP-3 Lys45Glu （rs679620） polymorphism with ischemic stroke and its TOAST subtypes. Methods The patients with large artery atherosclerotic stroke （LAA） and small artery occlusion stroke （SAO） according to TOAST etiological typing （ischemic stroke goup） and healthy subjects （control group） were enrolled. The enzyme-linked immunosorbent assay was used to detect plasma MMP-3 level. The polymerase chain reaction-restriction fragment length polymorpbism （PCR-RFLP） was used to detect the genotypes of MMP-3 Lys45Glu. Results A total of 233 patients with ischemic stroke were enrolled, in which 162 were LAA and 71 were SAO; 200 healthy subjects were taken as controls. The plasma MMP-3 level in the ischemic stroke group was significantly higher than that in the control group （253.99 ± 75.02 ng/ml vs. 196. 38 ± 78. 17 ng/ml; t =7. 813, P =0. 000）. The plasma MMP-3 level in the LAA group （262. 81 ±69. 23 ng/ml） was significantly higher than those in the groups of SAO （233.85 ± 83.90 ng/ml, P = 0. 008） and control （P = 0. 000）, and the plasma MMP-3 level in the SAO was also significantly higher than that in the control group （P = 0. 000）. Multivariate logistic regression analysis showed that the increased serum MMP-3 level was an independent risk factor for ischemic stroke （odds ratio [ OR] 1. 012, 95% confidence interval [ CI] 1. 008 - 1. 015; P =0. 000）. There was no sigrtificant difference in the frequencies of genotype （X2 = 2. 085, P =0. 353） and allele （X^2 = 2. 29, P =0. 130） of MMP-3 Lys45Glu between the ischemic stroke group and the control group. However, there were significant difference in MMP-3 Lys45Glu genotype frequencies among the groups of LAA, SAO and control （X^2 = 10.39,P=0.034）. The AA ＋GA genotype frequency in the LAA group was significant higher than those in the groups of SAO （65.4% vs. 49. 3% ;X^2 =5. 375, P =0. 020） and control （65.4% vs. 54. 0% ;X^2 =4. 84, P =0. 028）. There was no significant difference in the allele frequencies among the groups of LAA, SAO and control （X^2 =3. 887, P =0. 143）. Multivariate logistic regression analysis showed that MMP-3 Lys45Glu polymorphism was an independent risk factor for LAA （OR 1. 783, 95% CI 1. 183 - 2. 688; P = 0. 006）. The plasma MMP-3 level in patients with the genotypes AA （n =73）, GA （n = 176） and GG （n = 184） were 235. 70 ± 70. 85 ng/ml, （244. 20 ± 85. 90 ng/ml and 207. 98 ± 77. 61 ng/ml. There were significant difference in the plasma MMP-3 levels among the patients with the gmotypes AA, GA and GG （F =9. 682, P = 0. 000）. The plasma MMP-3 level in the patients with the genotype AA ＋ GA was significantly higher than that in patients with genotype GG （241.71 -± 81.73 ng/ml vs. 207. 98 ± 77. 61 ng/ml; t = 4. 336, P = 0. 000）. Conclusions The plasma MMP-3 level increased in patients with LAA or SAO, especially in the patients with LAA. The MMP-3 Lys45Glu polymorphism might be associated with the plasma MMP-3 level and LAA. Key words: Matrix MetaUoproteinase 3; Polymorphism, Genetic; Stroke; Brain Ischemia

The role of MMP-3 5A/6A Polymorphism in Acute Coronary Syndrome

Variations in Matrix Metalloproteinase-1, -3, and -9 Genes and the Risk of Acute Coronary Syndrome and Coronary Artery Disease in the Chinese Han Population.

Association Between Polymorphisms of Inflammatory Factor Genes and Coronary Heart Disease

The clinic relevance between acute coronary syndrome and the level of serum matrix metalloproteinase-9

Study of Relations Between Matrix Metalloproteinase-9 Polymorphism(c-1562T) and Acute Coronary Syndrome in Han Population of China

Clinical significance of serum interleukin-18 (IL-18) and matrix metalloproteinase-(MMP-9) on acute coronary syndrome

The relationship of the gene polymorphisms of matrix metalloproteinase-1, -2, -3 and -9 to the progression of coronary atherosclerotic plaque

Impact Of Matrix Metalloproteinase-1 Gene Variations On Risk Of Acute Coronary Syndrome

Association of Serum ADAMTS7 Levels and Genetic Variant Rs1994016 with Acute Coronary Syndrome in a Chinese Population: A Case Control Study.

[Matrix Metalloproteinase-1 Gene -519A/G Polymorphism and the Risk of Coronary Heart Disease in Northern Chinese Han Population].

Genetic Polymorphism of Matrix Metalloproteinase-1 and Coronary Artery Disease Susceptibility: a Case-Control Study in a Han Chinese Population.

The clinical role of increase of serum matrix metalioproteinase-8 concentration in patients with acute coronary syndrome

Relationship Between Matrix Metalloproteinase-2/9 Polymorphism and Susceptibility to Premature Coronary Heart Disease

Correlation Between Lys45 Glu Polymolphism of Matrix Metalloproteinase-3 and Ischenic Stroke Subtypes

Role of Matrix Metalloproteases 1/3 Gene Polymorphisms in Patients with Rotator Cuff Tear

[The Correlation Between Polymorphisms of Matrix Metalloproteinase-2 and -9 Genes and Colorectal Cancer of Chinese Patients].

Polymorphisms on chromosome 9p21 confer a risk for acute coronary syndrome in a Chinese Han population.

Polymorphism in the matrix metallopeptidase genes is associated with coronary artery disease risk with concomitant metabolic syndrome

Matrix Metalloproteinase-9 Polymorphism(C1562T) and the Susceptibility to Myocardial Infaction in Han Population of China

Polymorphisms in the ApoM gene confer the susceptibility to acute coronary syndrome

Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population